Data continue to show that tirzepatide, called Mounjaro for type 2 diabetes and Zepbound for weight loss, is safe and effective, but side effects remain.

Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo, according to the ...

Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?

A 2023 clinical trial found that stopping tirzepatide (the generic for ... with at least one weight-related condition, such as high blood pressure, heart disease, or obstructive sleep apnea.

Tirzepatide, a weight loss drug, shows promise in preventing diabetes by improving insulin sensitivity and aiding in weight ...

Novo Nordisk is finally facing some major competition to its obesity franchise juggernaut, now that Eli Lilly’s rival therapy tirzepatide ... such as high blood pressure, high cholesterol ...

People taking the weight loss drug Zepbound experienced dramatically greater weight loss than competitor Wegovy in the first head-to-head trial.

Cardiometabolic Health Markers: In addition to weight and diabetes risk reduction, tirzepatide use improved several cardiometabolic markers, including waist circumference, blood pressure ...

Tirzepatide has been approved for treating ... or overweight and at least one weight-related condition, such as high blood pressure or high cholesterol. If you’re interested in learning more ...